The Effects of Self-monitoring With a Mobile Application in Heart Failure
A Patient-centered Mobile Intervention to Promote Self-management and Improve Patient Outcomes in Chronic Heart Failure
1 other identifier
interventional
83
1 country
2
Brief Summary
In the United States, about 40 percent of heart failure (HF) patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 70 percent of the costs of HF management. As a result, the management of HF patients is evolving from the traditional model of face-to-face follow-up visits toward a proactive real-time technological model of assisting patients with monitoring and self-management while in the community. The investigators plan to test the impact of a mobile application on clinical outcomes in HF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Mar 2017
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 6, 2017
CompletedFirst Submitted
Initial submission to the registry
April 20, 2017
CompletedFirst Posted
Study publicly available on registry
May 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2019
CompletedApril 2, 2020
April 1, 2020
2.2 years
April 20, 2017
April 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Minnesota Living with Heart Failure Questionnaire (MLHFQ)
MLHFQ is a quality of life questionnaire for heart failure.
Change from Baseline MLHFQ at Week 12
Secondary Outcomes (3)
Self-Care Heart Failure Index (SCHFI)
Change from Baseline SCHFI at Week 12
Hospitalizations
Over 12 weeks
Mortality
Over 12 weeks
Study Arms (2)
Mobile Application
EXPERIMENTALParticipants will be using a mobile application, activity monitor and scale.
Control Group
NO INTERVENTIONParticipants will receive standard of care.
Interventions
Participants will use the mobile application daily to assess heart failure symptoms.
Eligibility Criteria
You may qualify if:
- years old or older
- Left ventricular ejection fraction \</= 40% or an LVEF \> 40% (with left atrial size \>40mm or BNP \> 200 pg/ml or NT-proBNP \> 800 pg/ml)
- Admitted for acutely decompensated heart failure or recently discharged in the past 4 weeks.
- Smartphone (iOS or Android) with home wifi
You may not qualify if:
- Unstable coronary syndrome within 8 weeks (unstable angina, NSTEMI, STEMI)
- Primary valvular heart disease
- Known pericardial disease (Sarcoidosis, amyloidosis, rheumatoid arthritis, lupus)
- Uncorrected thyroid disease
- Advanced renal disease (dialysis or creatinine \>4.0 mg/dL)
- End-stage HF (hospice candidate, home milrinone or dobutamine)
- Active cancer
- Pulmonary fibrosis
- Discharge to a setting other than home
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Michigan
Ann Arbor, Michigan, 48109-2054, United States
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
Related Publications (3)
Dorsch MP, Farris KB, Bleske BE, Koelling TM. A web application for self-monitoring improves symptoms in chronic systolic heart failure. Telemed J E Health. 2015 Apr;21(4):267-70. doi: 10.1089/tmj.2014.0095. Epub 2015 Feb 5.
PMID: 25654615BACKGROUNDBleske BE, Dillman NO, Cornelius D, Ward JK, Burson SC, Diez HL, Pickworth KK, Bennett MS, Nicklas JM, Dorsch MP. Heart failure assessment at the community pharmacy level: a feasibility pilot study. J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):634-41. doi: 10.1331/JAPhA.2014.14039.
PMID: 25379983BACKGROUNDDorsch MP, Farris KB, Rowell BE, Hummel SL, Koelling TM. The Effects of the ManageHF4Life Mobile App on Patients With Chronic Heart Failure: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2021 Dec 7;9(12):e26185. doi: 10.2196/26185.
PMID: 34878990DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Todd M Koelling, MD
University of Michigan Heart Failure Program
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
April 20, 2017
First Posted
May 11, 2017
Study Start
March 6, 2017
Primary Completion
April 30, 2019
Study Completion
April 30, 2019
Last Updated
April 2, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share